(Q39036600)

8 September 2017

title

Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells (English)

1 reference

8 September 2017

0 references

12

1 reference

8 September 2017

Eleni Anastasiadou

1

0 references

Neeha Garg

Neha Garg

2

0 references

Antonio F Campese

Antonio Francesco Campese

5

0 references

Caterina Lapenta

Caterina Lapenta

6

0 references

Annalisa Botta

Annalisa Botta

9

0 references

Filippo Belardelli

Filippo Belardelli

10

0 references

author name string

Rachele Bigi

3

1 reference

8 September 2017

Shivangi Yadav

4

1 reference

8 September 2017

Massimo Spada

7

1 reference

8 September 2017

Laura Cuomo

8

1 reference

8 September 2017

Luigi Frati

11

1 reference

8 September 2017

Alberto Faggioni

13

1 reference

8 September 2017

Pankaj Trivedi

14

1 reference

8 September 2017

language of work or name

English

0 references

publication date

4 March 2015

1 reference

International Journal of Cancer

8 September 2017

published in

1 reference

8 September 2017

volume

137

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

1491-1497

1 reference

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

8 September 2017

cites work

1 reference

Clinical outcome prediction by microRNAs in human cancer: a systematic review

21 January 2018

1 reference

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

21 January 2018

1 reference

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma

21 January 2018

1 reference

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

Plasma cell myeloma associated with Epstein-Barr virus infection in an 11-year-old girl

21 January 2018

1 reference

Plasmablastic extramedullary plasmacytoma associated with Epstein-Barr virus arising in an immunocompetent patient with multiple myeloma

21 January 2018

1 reference

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

21 January 2018

1 reference

Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth

21 January 2018

1 reference

MicroRNA profiles of drug-resistant myeloma cell lines.

21 January 2018

1 reference

Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b

21 January 2018

1 reference

Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2.

21 January 2018

1 reference

Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells

21 January 2018

1 reference

The viral and cellular microRNA targetome in lymphoblastoid cell lines

21 January 2018

1 reference

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells

21 January 2018

1 reference

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

21 January 2018

1 reference

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes

21 January 2018

1 reference

miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism

21 January 2018

1 reference

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

Epstein-Barr virus growth/latency III program alters cellular microRNA expression

21 January 2018

1 reference

Epstein-Barr virus-mediated dysregulation of human microRNA expression

21 January 2018

1 reference

EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29489

1 reference

8 September 2017

1 reference